6
Clinical Trials associated with SHR-3167A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 Injection at Steady State in Subjects With Type 2 Diabetes
The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.
/ Not yet recruitingPhase 1IIT A phase I clinical trial evaluating the pharmacokinetics, pharmacodynamics and safety of multiple-dose SHR-3167 injection in type 2 diabetic subjects at steady state.
/ Not yet recruitingPhase 2 A Randomized, Open-label, Treat-to-target, Parallel-Controlled Phase II Clinical Study Investigating the Efficacy and Safety of SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
The purpose of this study is to evaluate the glycemic control and safety of SHR-3167 and Insulin Degludec in type 2 diabetic participants treated with basal insulin with or without oral antidiabetic drugs.
100 Clinical Results associated with SHR-3167
100 Translational Medicine associated with SHR-3167
100 Patents (Medical) associated with SHR-3167
100 Deals associated with SHR-3167